Roche CEO Severin Schwan Fueled By Innovation, Emerging Markets: An Interview With PharmAsia News

Roche CEO Severin Schwan says the Swiss group’s recent revamps, lack of patent expiries, and ongoing drug innovations give the world’s largest maker of cancer drugs a strong position to expand its sales globally, helped by new cutting-edge therapies and creative business approaches.